HCFC1 variants in the proteolysis domain are associated with X‐linked idiopathic partial epilepsy: Exploring the underlying mechanism
Authors:
Open Access
- 1 June 2023
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 13 (6) , e1289
Abstract
Background: HCFC1 encodes transcriptional co‐regulator HCF‐1, which undergoes an unusual proteolytic maturation at a centrally located proteolysis domain. HCFC1 variants were associated with X‐linked cobalamin metabolism disorders and mental retardation‐3. This study aimed to explore the role of HCFC1 variants in common epilepsy and the mechanism underlying phenotype heterogeneity.Methods: Whole‐exome sequencing was performed in a cohort of 313 patients with idiopathic partial (focal) epilepsy. Functional studies determined the effects of the variants on the proteolytic maturation of HCF‐1, cell proliferation and MMACHC expression. The role of HCFC1 variants in partial epilepsy was validated in another cohort from multiple centers.Results: We identified seven hemizygous HCFC1 variants in 11 cases and confirmed the finding in the validation cohort with additional 13 cases and six more hemizygous variants. All patients showed partial epilepsies with favorable outcome. None of them had cobalamin disorders. Functional studies demonstrated that the variants in the proteolysis domain impaired the maturation by disrupting the cleavage process with loss of inhibition of cell growth but did not affect MMACHC expression that was associated with cobalamin disorder. The degree of functional impairment was correlated with the severity of phenotype. Further analysis demonstrated that variants within the proteolysis domain were associated with common and mild partial epilepsy, whereas those in the kelch domain were associated with cobalamin disorder featured by severe and even fatal epileptic encephalopathy, and those in the basic and acidic domains were associated with mainly intellectual disability.Conclusion: HCFC1 is potentially a candidate gene for common partial epilepsy with distinct underlying mechanism of proteolysis dysfunction. The HCF‐1 domains played distinct functional roles and were associated with different clinical phenotypes, suggesting a sub‐molecular effect. The distinct difference between cobalamin disorders and idiopathic partial epilepsy in phenotype and pathogenic mechanism, implied a clinical significance in early diagnosis and management.Keywords
Funding Information
- National Natural Science Foundation of China (81971216 to HN, 82171439 to SYW, 82071548 to TB)
This publication has 37 references indexed in Scilit:
- Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikesNature Genetics, 2013
- HCFC1 is a common component of active human CpG-island promoters and coincides with ZNF143, THAP11, YY1, and GABP transcription factor occupancyGenome Research, 2013
- A Noncoding, Regulatory Mutation Implicates HCFC1 in Nonsyndromic Intellectual DisabilityThe American Journal of Human Genetics, 2012
- O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1Cell, 2011
- Role of the HCF-1 Basic Region in Sustaining Cell ProliferationPLOS ONE, 2010
- Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4)European Journal of Human Genetics, 2009
- The HCF repeat is an unusual proteolytic cleavage signal.Genes & Development, 1995
- The gene encoding the VP16-accessory protein HCF (HCFC1) resides in human Xq28 and is highly expressed in fetal tissues and the adult kidneyGenomics, 1995
- The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor proteinCell, 1993
- Localisation of the MRX3 gene for non-specific X linked mental retardation.Journal of Medical Genetics, 1991